Assessment of CMV infection in allo-HSCT recipients undergoing LMV prophylaxis by using an implemented diagnostic protocol to identify active viral replication
Giulia Piccirilli(Azienda USL di Bologna), Prof Tiziana Lazzarotto(Azienda USL di Bologna), E Borgatti(University of Bologna), Alessia Cantiani(University of Bologna), Margherita Ursi(Azienda USL di Bologna), Marcello Roberto(Azienda USL di Bologna), Francesco De Felice(Azienda USL di Bologna), Federica Lanna(University of Bologna), Enrico Maffini(Istituto di Ematologia di Bologna), Sadia Falcioni, Martina Franceschiello(University of Bologna), Federica Ardizzoia(Istituto di Ematologia di Bologna), Francesca Bonifazi(Istituto di Ematologia di Bologna), Michele Dicataldo(Azienda Ospedaliera Citta' della Salute e della Scienza di Torino), Liliana Gabrielli(Azienda USL di Bologna), Martina Tamburello(University of Bologna)
Cited by 0
Related Papers
Neurologic Complications after Allogeneic Hematopoietic Stem Cell Transplantation
|Transplantation and Cellular Therapy|2016|106
Drug-induced thrombotic microangiopathy: An updated review of causative drugs, pathophysiology, and management
|Frontiers in Pharmacology|2023|81
CD22 Expression in B-Cell Acute Lymphoblastic Leukemia: Biological Significance and Implications for Inotuzumab Therapy in Adults
|Cancers|2020|78
The Advent of CAR T-Cell Therapy for Lymphoproliferative Neoplasms: Integrating Research Into Clinical Practice
|Frontiers in Immunology|2020|71
Treatment of CMV infection after allogeneic hematopoietic stem cell transplantation
|Expert Review of Hematology|2016|57